[COVID-19, severe asthma, and biologic]
- PMID: 33771438
- PMCID: PMC7969857
- DOI: 10.1016/j.rmr.2021.03.002
[COVID-19, severe asthma, and biologic]
Keywords: Asthme sévère; Biologic; Biothérapies; COVID-19; SARS-CoV-2; Severe asthma.
References
-
- Chung K.F., Wenzel S.E., Brozek J.L. International ERS/ATS guidelines on definition, evaluation andtreatment of severe asthma. Eur Respir J. 2014;43:343–373. - PubMed
-
- Bourdin A., Fabry-Vendrand C., Ostinelli J. The burden of severe asthma in France: A case-control study using a medical claims database. J Allergy Clin Immunol Pract. 2019;7:1477–1487. - PubMed
-
- Global Initiative for Asthma . 2020. Global Strategy for Asthma Management and Prevention. Disponible sur: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-... (consulté le 20 janvier 2021)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous